EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder

Jonathan Brett, Elizabeth Knock, P Todd Korthuis, Paul Liknaitzky, Kevin S Murnane, Christopher R Nicholas, James C Patterson, Christopher S Stauffer

Frontiers in Psychiatry · 14.03.2023 · 14

DOI: 10.3389/fpsyt.2023.1123424 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Psychiatry, online erschienen am 14.03.2023. Verfasst von Jonathan Brett und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, St. Vincent's Hospital, Sydney, NSW, Australia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methamphetamine use disorder is a chronic relapsing condition associated with substantial mental, physical, and social harms and increasing rates of mortality. Contingency management and psychotherapy interventions are the mainstays of treatment but are modestly effective with high relapse rates, while pharmacological treatments have shown little to no efficacy. Psilocybin-assisted psychotherapy is emerging as a promising treatment for a range of difficult-to-treat conditions, including substance use disorders; however, no studies have yet been published looking at psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Here we review the rationale for psilocybin-assisted psychotherapy as a potential treatment for this indication, and describe practical considerations based on our early experience designing and implementing four separate clinical trials of psilocybin-assisted psychotherapy for methamphetamine use disorder.

Schlagwörter

Stichwörter der Autor:innen

Addiction Medicinemethamphetaminemethamphetamine use disorderpsilocybinpsilocybin-assisted psychotherapystimulant use disorder

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, St. Vincent's Hospital, Sydney, NSW, Australia.
  • School of Population Health, Medicines Intelligence Centre of Research Excellence, University of New South Wales, Sydney, NSW, Australia.
  • Alcohol and Drug Service, St. Vincent's Hospital, Sydney, NSW, Australia.
  • Section of Addiction Medicine, Oregon Health & Science University, Portland, OR, United States.
  • Department of Psychiatry, School of Clinical Sciences, Monash University, Caulfield, VIC, Australia.
  • Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Caulfield, VIC, Australia.

Zitieren

APA

Brett, J., Knock, E., Korthuis, P. T., Liknaitzky, P., Murnane, K. S., Nicholas, C. R., Patterson, J. C., & Stauffer, C. S. (2023). Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1123424

Vancouver

Brett J, Knock E, Korthuis PT, Liknaitzky P, Murnane KS, Nicholas CR, et al. Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. Frontiers in Psychiatry. 2023;14. doi:10.3389/fpsyt.2023.1123424

BibTeX
@article{Brett2023,
  author = {Brett, Jonathan and Knock, Elizabeth and Korthuis, P Todd and Liknaitzky, Paul and Murnane, Kevin S and Nicholas, Christopher R and Patterson, James C and Stauffer, Christopher S},
  title = {Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder},
  journal = {Frontiers in Psychiatry},
  year = {2023},
  volume = {14},
  doi = {10.3389/fpsyt.2023.1123424}
}
Kostenlos starten →